Right hippocampus atrophy is independently associated with Alzheimer's disease with psychosis

被引:19
|
作者
Lee, Kangyoon [1 ,2 ]
Lee, Young Min [1 ,2 ]
Park, Je-Min [1 ,2 ]
Lee, Byung-Dae [1 ,2 ]
Moon, Eunsoo [1 ,2 ]
Jeong, Hee-Jeong [1 ,2 ]
Kim, Soo Yeon [1 ,2 ]
Chung, Young-In [3 ]
Kim, Ji-Hoon [3 ]
机构
[1] Pusan Natl Univ, Dept Psychiat, Sch Med, 179 Gudeok Ro, Busan, South Korea
[2] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea
[3] Pusan Natl Univ, Dept Psychiat, Sch Med, Yangsan, South Korea
关键词
Alzheimer's disease; hippocampus; psychosis; HIGH-RISK; SCHIZOPHRENIA; ABNORMALITIES; DELUSIONS; SYMPTOMS; DEMENTIA; MRI; METAANALYSIS; DIAGNOSIS; VOLUME;
D O I
10.1111/psyg.12369
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Aim The purpose of this study was to determine whether regionally distributed medial temporal cortex thickness (or hippocampal volume) and frontal lobe volume are independently associated with the onset of Alzheimer's disease (AD) with psychosis. Methods We identified 26 AD patients with psychosis (AD+P) and 48 AD patients without psychosis (AD-P) from the Memory Impairment Clinic at Pusan National University Hospital in South Korea. They were matched for age, gender, duration of AD, and Clinical Dementia Rating sum of box score. All participants met the National Institute of Neurological and Communication Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria for probable AD. Psychosis was diagnosed according to Jeste and Finkel's proposed diagnostic criteria for psychosis of AD. All participants underwent 3-T magnetic resonance imaging, and 3-D magnetization-prepared rapid gradient echo sequence was acquired for each. The FreeSurfer version 5.1 software package was used to analyze cortical thickness and volume on 3-D T-1-weighted images. anova was used to investigate the differences in cortical thickness and the volume of the total frontal cortex, total temporal cortex, and subregions of the medial temporal cortex between groups after age, gender, years of education, Clinical Dementia Rating sum of box score, duration of AD, and total intracranial volume were controlled for. Furthermore, we added the total frontal volume as an additional variable to investigate whether the association between the medial temporal cortex and AD+P is independent of the frontal cortex. Results We found that both left and right hippocampal volume were smaller in AD+P than in AD-P. In particular, there was a significant difference in right hippocampal volume between the AD+P and AD-P groups after total frontal volume was added as an additional variable. Conclusion We found that more severe hippocampal atrophy is associated with AD+P than with AD-P. In addition, atrophy of the right hippocampus remained significant among AD+P after adjustment for frontal volume. These findings suggest that right hippocampal atrophy is independently associated with AD+P.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 50 条
  • [11] Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative
    Meda, Shashwath A.
    Koran, Mary Ellen I.
    Pryweller, Jennifer R.
    Vega, Jennifer N.
    Thornton-Wells, Tricia A.
    NEUROBIOLOGY OF AGING, 2013, 34 (05) : 1518.e9 - 1518.e18
  • [12] Challenges and proposed solutions to conducting Alzheimer's disease psychosis trials
    Ballard, Clive
    Tariot, Pierre
    Soto-Martin, Maria
    Pathak, Sanjeev
    Liu, I-Yuan
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [13] Cortical complexity alterations in the medial temporal lobe are associated with Alzheimer's disease psychosis
    D'Antonio, Fabrizia
    Di Vita, Antonella
    Zazzaro, Giulia
    Canevelli, Marco
    Trebbastoni, Alessandro
    Campanelli, Alessandra
    Ferracuti, Stefano
    de Lena, Carlo
    Guariglia, Cecilia
    Boccia, Maddalena
    AGING NEUROPSYCHOLOGY AND COGNITION, 2022, 29 (06) : 1022 - 1032
  • [14] A specific pattern of gray matter atrophy in Alzheimer's disease with depression
    Karavasilis, Efstratios
    Parthimos, Theodore P.
    Papatriantafyllou, John D.
    Papageorgiou, Sokratis G.
    Kapsas, George
    Papanicolaou, Andrew C.
    Seimenis, Ioannis
    JOURNAL OF NEUROLOGY, 2017, 264 (10) : 2101 - 2109
  • [15] Why psychosis is frequently associated with Parkinson's disease?
    Zhong, Jingmei
    Wu, Shaoyuan
    Zhao, Ying
    Chen, Hui
    Zhao, Naiwei
    Zheng, Kunwen
    Zhao, Zhong
    Chen, Wenli
    Wang, Bo
    Wu, Kunhua
    NEURAL REGENERATION RESEARCH, 2013, 8 (27) : 2548 - 2556
  • [16] Frontotemporal atrophy associated with paranoid delusions in women with Alzheimer's disease
    Whitehead, D.
    Tunnard, C.
    Hurt, C.
    Wahlund, L. O.
    Mecocci, P.
    Tsolaki, M.
    Vellas, B.
    Spenger, C.
    Ktoszewska, I.
    Soininen, H.
    Cromb, D.
    Lovestone, S.
    Simmons, A.
    INTERNATIONAL PSYCHOGERIATRICS, 2012, 24 (01) : 99 - 107
  • [17] Muscle Strength Is Independently Related to Brain Atrophy in Patients with Alzheimer's Disease
    Moon, Yeonsil
    Moon, Won-Jin
    Kim, In Ok
    Kwon, Kyoung Ja
    Han, Seol-Heui
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2019, 47 (4-6) : 306 - 314
  • [18] Pathomechanisms of Atrophy in Insular Cortex in Alzheimer's Disease
    Moon, Yeonsil
    Moon, Won-Jin
    Han, Seol-Heui
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2015, 30 (05): : 497 - 502
  • [19] Psychosis in Alzheimer's Disease is Associated with Frontal Metabolic Impairment and Accelerated Decline in Working Memory: Findings from the Alzheimer's Disease Neuroimaging Initiative
    Koppel, Jeremy
    Sunday, Suzanne
    Goldberg, Terry E.
    Davies, Peter
    Christen, Erica
    Greenwald, Blaine S.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 22 (07) : 698 - 707
  • [20] PROTEOMIC DYSREGULATION ASSOCIATED WITH PSYCHOSIS IN ALZHEIMER'S DISEASE
    Nucifora, Leslie
    Gomez-Isaza, Laura
    Lee, Brian
    Ross, Christopher
    Margolis, Russell
    Smith, Gwenn
    Kofler, Julia
    Sweet, Robert
    Nucifora, Frederick
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 347 - 347